Granules India clarified that its growth trajectory remains robust and diversified and that its strategy is not solely ...

The End-of-Phase 2 meeting resulted in alignment with the FDA on the proposed Phase 3 study design, including the inclusion/exclusion criteria, primary and secondary efficacy objectives, definition of ...

Makers of flavored e-cigarettes brought various cases challenging the FDA’s decision to refuse approval and alleged the ...

Faces Securities Class Action Lawsuit Over Alleged Safety Risks of Zenrelia, December 6th Deadline Pending - Hagens Berman ...

The FDA's Orphan Drug Designation is intended to encourage the development of treatments for rare diseases. Orphan Drug Designation offers benefits including seven years of market exclusivity ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

(UroToday.com) The 2024 SUO annual meeting included a session on non muscle invasive bladder cancer, featuring a presentation by Dr. Ashish Kamat discussing BCG unresponsive cancer in 2024.

"We are thankful for the steady pace of site activations and continued brisk enrollment with our recently activated sites already contributing,” said Kevin Chung, MD, Chief Medical Officer of SeaStar ...

Exploring regulatory challenges in global pharmaceutical market: Dr. Malini Saba Wednesday, December 4, 2024, 08:00 Hrs [IST] Pharmaceutical industry operates in a highly regulate ...

Projections indicate that pancreatic cancer could become the second most common cause of cancer death by 2030.William Hawkins ...

Myasthenia gravis, or MG, is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue.

MIAMI, FL / / December 3, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), an emerging leader in age-reversal science, today announced groundbreaking preclinical ...